Adams, R. A., Meade, A. M., Seymour, M. T., Wilson, R. H., Madi, A., Fisher, D., . . . Maughan, T. S. (2011). Intermittent versus continuous oxaliplatin and fluoropyrimidine combination chemotherapy for first-line treatment of advanced colorectal cancer: Results of the randomised phase 3 MRC COIN trial. Lancet Pub. Group.
Chicago Style CitationAdams, Richard A., et al. Intermittent Versus Continuous Oxaliplatin and Fluoropyrimidine Combination Chemotherapy for First-line Treatment of Advanced Colorectal Cancer: Results of the Randomised Phase 3 MRC COIN Trial. Lancet Pub. Group, 2011.
MLA CitationAdams, Richard A., et al. Intermittent Versus Continuous Oxaliplatin and Fluoropyrimidine Combination Chemotherapy for First-line Treatment of Advanced Colorectal Cancer: Results of the Randomised Phase 3 MRC COIN Trial. Lancet Pub. Group, 2011.